Neomics' Series A Round

Neomics raised a round of funding on October 03, 2008. Investors include Novartis Venture Funds.

Neomics is a drug discovery and diagnostics company with a unique cancer target and biomarker discovery platform. In particular, Neomics is focused on novel targets and biomarkers relevant to aminoacy…

Articles about Neomics' Series A Round: